Genetesis CardioFlux platform receives FDA 510(k) clearance
IMAGE: Patient, monitored by nurse, in a Genetesis Cardioflux™ scanner. view more (Mason, OH March 22, 2019 8 am) Genetesis, a medical technology company focused on using biomagnetic imaging to enable rapid, noninvasive and accurate chest pain triage, has received FDA 510(k) clearance for its cardiac imaging platform. The platform pairs the CardioFlux™ Magnetocardiograph with the…
Details